Literature DB >> 18034769

Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants.

M M Samama, L Le Flem, C Guinet, G Gerotziafas, F Depasse.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 18034769     DOI: 10.1111/j.1538-7836.2007.02753.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  9 in total

1.  In vitro studies using a global hemostasis assay to examine the anticoagulation effects in plasma by the direct thrombin inhibitors: dabigatran and argatroban.

Authors:  Shu He; Håkan Wallèn; Niklas Bark; Margareta Blombäck
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

2.  Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.

Authors:  Jennifer L Aron; Robert Gosselin; Stephan Moll; Charles F Arkin; Simon Mantha
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 3.  Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development.

Authors:  Bengt I Eriksson; Daniel J Quinlan; Jeffrey I Weitz
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study.

Authors:  Meyer Michel Samama; Céline Guinet; Léna Le Flem; Emmanuel Ninin; Jean-Marc Debue
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

Review 5.  Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.

Authors:  Joachim Stangier
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

6.  Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study.

Authors:  Argirios E Tsantes; Elias Kyriakou; Ignatios Ikonomidis; Konstantinos Katogiannis; Ioannis Papadakis; Panagiota Douramani; Petros Kopterides; Violetta Kapsimali; John Lekakis; Iraklis Tsangaris; Stefanos Bonovas
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

7.  The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.

Authors:  Hongxia Li; Lei Zhang; Ming Xia; Chi Zhang; Tingbo Jiang
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 8.  Clinical use of thrombin generation assays.

Authors:  Nikolaus B Binder; François Depasse; Julia Mueller; Thomas Wissel; Stephan Schwers; Matthias Germer; Björn Hermes; Peter L Turecek
Journal:  J Thromb Haemost       Date:  2021-10-08       Impact factor: 16.036

9.  Differential Assessment of Factor Xa Activity and Global Blood Coagulability Utilizing Novel Dielectric Coagulometry.

Authors:  Satomi Hamada; Yuki Hasegawa; Ai Oono; Anna Suzuki; Naomi Takahashi; Takuro Nishimura; Takatoshi Koyama; Michio Hagihara; Shuji Tohda; Tetsushi Furukawa; Kenzo Hirao; Tetsuo Sasano
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.